Proscia Raises $37M Series C To Fulfill The Promise Of Precision Medicine With AI-Enabled Pathology
Published: June 21, 2022
14th June 2022 – Contributions by Steve Holloway – Featured on Proscia’s website – Proscia®, a leader in digital and computational pathology solutions, has raised $37 million to advance the way we understand and treat diseases like cancer. The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers, and Razor’s Edge Ventures. This investment brings Proscia’s total funding to $72 million.Share on LinkedIn
Digital PathologyPublishing March 2023
This is a brochure for Signify Research’s 2023 report on the global market for Digital Pathology publishing in March 2023.
Find out more